15 related articles for article (PubMed ID: 38537805)
1. Joining up the scattered anticancer knowledge on auraptene and umbelliprenin: a meta-analysis.
Shakiba M; Rassouli FB
Sci Rep; 2024 May; 14(1):11770. PubMed ID: 38783034
[TBL] [Abstract][Full Text] [Related]
2. Galbanic acid suppresses melanoma cell migration and invasion by reducing MMP activity and downregulating N-cadherin and fibronectin.
Azad M; Hosseini F; Hassanzade H; Gharedaghi S; Mahdipour E; Rassouli FB; Jamialahmadi K
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; ():. PubMed ID: 38324091
[TBL] [Abstract][Full Text] [Related]
3. Cyano Enone-Bearing Triterpenoid Soloxolone Methyl Inhibits Epithelial-Mesenchymal Transition of Human Lung Adenocarcinoma Cells In Vitro and Metastasis of Murine Melanoma In Vivo.
Markov AV; Odarenko KV; Sen'kova AV; Salomatina OV; Salakhutdinov NF; Zenkova MA
Molecules; 2020 Dec; 25(24):. PubMed ID: 33327637
[TBL] [Abstract][Full Text] [Related]
4. Brucine suppresses breast cancer metastasis via inhibiting epithelial mesenchymal transition and matrix metalloproteinases expressions.
Li M; Li P; Zhang M; Ma F
Chin J Integr Med; 2018 Jan; 24(1):40-46. PubMed ID: 28795388
[TBL] [Abstract][Full Text] [Related]
5. Auraptene Inhibits Migration and Invasion of Cervical and Ovarian Cancer Cells by Repression of Matrix Metalloproteinasas 2 and 9 Activity.
Jamialahmadi K; Salari S; Alamolhodaei NS; Avan A; Gholami L; Karimi G
J Pharmacopuncture; 2018 Sep; 21(3):177-184. PubMed ID: 30283705
[TBL] [Abstract][Full Text] [Related]
6. A combined modality of carboplatin and photodynamic therapy suppresses epithelial-mesenchymal transition and matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in HEp-2 human laryngeal cancer cells via ROS-mediated inhibition of MEK/ERK signalling pathway.
Mao W; Sun Y; Zhang H; Cao L; Wang J; He P
Lasers Med Sci; 2016 Nov; 31(8):1697-1705. PubMed ID: 27481258
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of melanoma cell migration and invasion by natural coumarin auraptene through regulating EMT markers and reducing MMP-2 and MMP-9 activity.
Hosseini F; Ahmadi A; Hassanzade H; Gharedaghi S; Rassouli FB; Jamialahmadi K
Eur J Pharmacol; 2024 May; 971():176517. PubMed ID: 38537805
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
